These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 32780778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
    Rocha SP, Elias WP, Cianciarullo AM, Menezes MA, Nara JM, Piazza RM, Silva MR, Moreira CG, Pelayo JS.
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
    [Abstract] [Full Text] [Related]

  • 4. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.
    Li X, Lockatell CV, Johnson DE, Lane MC, Warren JW, Mobley HL.
    Infect Immun; 2004 Jan; 72(1):66-75. PubMed ID: 14688082
    [Abstract] [Full Text] [Related]

  • 5. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
    Pellegrino R, Scavone P, Umpiérrez A, Maskell DJ, Zunino P.
    Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly.
    Li X, Zhao H, Geymonat L, Bahrani F, Johnson DE, Mobley HL.
    Infect Immun; 1997 Apr; 65(4):1327-34. PubMed ID: 9119470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fimbriae of uropathogenic Proteus mirabilis.
    Rocha SP, Pelayo JS, Elias WP.
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
    [Abstract] [Full Text] [Related]

  • 16. Pathogenesis of Proteus mirabilis Infection.
    Armbruster CE, Mobley HLT, Pearson MM.
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [Abstract] [Full Text] [Related]

  • 17. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M, Asadi Karam MR, Shokrgozar MA, Oloomi M, Jafari A, Bouzari S.
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.
    White AN, Learman BS, Brauer AL, Armbruster CE.
    Infect Immun; 2021 Sep 16; 89(10):e0017721. PubMed ID: 34280035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.